Reshma Rangwala, EVP & Chief Medical Officer: Karyopharm Therapeutics KPTI Sell · Filed 04/22

Trade details

Type: Insider sale
Amount: $4,014.06
Shares · price: 449 sh · $8.94 a share
Held after: 56,290 sh
Stock: Karyopharm Therapeutics KPTI
Person: Reshma RangwalaEVP & Chief Medical Officer
Trade date: 26/04/21
Filed: 26/04/22
Days to filing: 1 days

Sold 0.8% of holdings

Share of holding sold: 0.8%

Karyopharm Therapeutics trades, last 26 weeks

What else happened in Karyopharm Therapeutics around then

Filed or reported within 30 days of the trade day · 03/22~05/21

Reshma Rangwala's recent trades

Reshma RangwalaEVP & Chief Medical Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$3,876
408 sh
$3,876
Filed 05/15
Traded 05/14
Reshma RangwalaEVP & Chief Medical Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$47.7K
5,066 sh
$47.7K
Filed 03/03
Traded 03/02
Reshma RangwalaEVP & Chief Medical Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$2,623
408 sh
$2,623
Filed 25/09/16
Traded 25/09/15
Reshma RangwalaEVP & Chief Medical Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$2,585
419 sh
$2,585
Filed 25/04/24
Traded 25/04/23
Reshma RangwalaEVP & Chief Medical Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$22.6K
3,587 sh
$22.6K
Filed 25/03/06
Traded 25/03/04